VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U6669AA: VAERS reports

20 VAERS reports list lot U6669AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2020-08-19 and 2022-09-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Allergic / Anaphylactic323%
Dermatological (non-injection-site)323%
Injection-site / Local reaction323%
Neurological18%
Respiratory18%
Musculoskeletal18%
Psychiatric / Neuropsychiatric18%

Where reports came from

U.S. state of the reporter, where given (top 12).

Iowa3
Ohio3
Texas2
Pennsylvania2
Florida2
Washington1
Virginia1
Minnesota1
Kentucky1
North Carolina1
Kansas1
Maryland1

Reports by month received

2020-081
2020-091
2020-102
2020-111
2020-121
2021-051
2021-061
2021-101
2021-121
2022-021
2022-051
2022-064
2022-082
2022-092

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.